Mutation of proline-1003 to glycine in the epidermal growth factor (EGF) receptor enhances responsiveness to EGF

SM Schuh, EP Newberry, MA Dalton and LJ Pike

Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110.

We have shown previously that the epidermal growth factor (EGF) receptor is phosphorylated at Ser-1002 and that this phosphorylation is associated with desensitization of the EGF receptor. Ser-1002 is followed immediately by Pro-1003, a residue that may promote the adoption of a specific conformation at this site or severe as a recognition element for the interaction of the EGF receptor with other proteins. To examine these possibilities, we have mutated Pro-1003 of the EGF receptor to a Gly residue and have analyzed the effect of this mutation on EGF-stimulated signaling. Cells expressing the P1003G EGF receptors exhibited higher EGF-stimulated autophosphorylation and synthetic peptide phosphorylation compared to cells expressing wild- type EGF receptors. In addition, the ability of EGF to stimulate PI 3- kinase activity and mitogen-activated protein kinase activity was enhanced in cells expressing the P1003G EGF receptor. Cells expressing P1003G receptors also demonstrated an increased ability to form colonies in soft agar in response to EGF. These results indicate that mutation of Pro-1003 leads to a potentiation of the biological effects of EGF. The findings are consistent with the hypothesis that Pro-1003 plays a role in a form of regulation that normally suppresses EGF receptor function.

Volume 5, Issue 7, pp. 739-746, 07/01/1994
Copyright © 1994 by The American Society for Cell Biology

This article has been cited by other articles:

				L. J. Pike and J. M. Miller Cholesterol Depletion Delocalizes Phosphatidylinositol Bisphosphate and Inhibits Hormone-stimulated Phosphatidylinositol Turnover J. Biol. Chem., August 28, 1998; 273(35): 22298 - 22304. [Abstract] [Full Text] [PDF]

				SunilD. Pandit, T. O'Hare, H. Donis-Keller, and LindaJ. Pike Functional Characterization of an Epidermal Growth Factor Receptor/RET Chimera J. Biol. Chem., January 24, 1997; 272(4): 2199 - 2206. [Abstract] [Full Text] [PDF]

				L. J. Pike and L. Casey Localization and Turnover of Phosphatidylinositol 4,5-Bisphosphate in Caveolin-enriched Membrane Domains J. Biol. Chem., October 25, 1996; 271(43): 26453 - 26456. [Abstract] [Full Text] [PDF]

				S. D. Pandit, H. Donis-Keller, T. Iwamoto, J. M. Tomich, and L. J. Pike The Multiple Endocrine Neoplasia Type 2B Point Mutation Alters Long-term Regulation and Enhances the Transforming Capacity of the Epidermal Growth Factor Receptor J. Biol. Chem., March 8, 1996; 271(10): 5850 - 5858. [Abstract] [Full Text] [PDF]